 SOUTH SAN FRANCISCO, Calif., Sept. 09, 2021 GLOBE NEWSWIRE -- Vera Therapeutics, Inc. Nasdaq: VERA, a clinical-stage biotechnology company focused on developing treatments for immunological diseases that improve patients lives, announced today that it is scheduled to host a key opinion leader KOL webinar on IgA Nephropathy IgAN or Bergers Disease at 12:00 p.m. ET on Monday, September 20, 2021. 